Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Teva Pharmaceuticals USA, Inc recalls Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen)

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Products
  • Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen)
Where it was sold

nationwide

Nationwide

Units affected
19,824 cartons
About this recall
Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton contains 6 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9012-58